Psych Trial Halted After Death; Curbing Phone Addiction; Most Worried Racial Group
The FDA halted patient enrollment in a phase III trial of evenamide in treatment-resistant schizophrenia following the sudden…
NRx submits 70,000-patient ketamine data to US FDA
NRx Pharmaceuticals (Nasdaq: NRXP) will submit real-world evidence from over 70,000 patients treated with intravenous ketamine…